SPY369.08+2.39 0.65%
DIA301.85+1.79 0.60%
IXIC12,452.46+75.27 0.61%

Poseida Therapeutics Q3 EPS $(0.63) Up From $(1.65) YoY

Poseida Therapeutics (NASDAQ:PSTX) reported quarterly losses of $(0.63) per share. This is a 61.82 percent increase over losses of $(1.65) per share from the same period last year.

· 11/12/2020 16:10
Poseida Therapeutics (NASDAQ:PSTX) reported quarterly losses of $(0.63) per share. This is a 61.82 percent increase over losses of $(1.65) per share from the same period last year.